sorafenib has been researched along with razoxane in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (razoxane) | Trials (razoxane) | Recent Studies (post-2010) (razoxane) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 824 | 115 | 56 |
| Protein | Taxonomy | sorafenib (IC50) | razoxane (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasinoff, BB; Patel, D | 1 |
1 other study(ies) available for sorafenib and razoxane
| Article | Year |
|---|---|
Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Apoptosis; Benzenesulfonates; Blotting, Western; Cardiotonic Agents; Caspase 3; Caspase 7; Cell Separation; Extracellular Signal-Regulated MAP Kinases; In Vitro Techniques; Iron Chelating Agents; L-Lactate Dehydrogenase; Microscopy, Fluorescence; Myocytes, Cardiac; Niacinamide; Oxidation-Reduction; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Razoxane; Sorafenib | 2010 |